Induction of Labor After Cesarean Using Foley Alone vs. Concurrent Foley and Oxytocin
Launched by UNIVERSITY OF PENNSYLVANIA · May 27, 2025
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the best way to help women who have had one previous Cesarean delivery to begin labor safely and effectively. The researchers want to find out if using a Foley catheter (a flexible tube used to help soften the cervix) alone is as effective as using it along with a medication called Oxytocin, which helps stimulate contractions. They hope that combining these two methods will lead to faster deliveries without increasing risks for the mothers or babies.
To participate in this trial, women must be at least 18 years old, have a single baby due in the next few weeks (at least 37 weeks of pregnancy), and have had only one previous Cesarean delivery. They should also be able to understand instructions in English or Spanish and have certain medical conditions that make them eligible for labor induction. If you join this study, you will be randomly assigned to one of the two groups and monitored closely throughout the process to ensure safety and gather important information about the outcomes. The trial is not yet recruiting participants, but it aims to provide valuable insights into labor induction methods for women with a history of Cesarean delivery.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Eligible for induction of labor
- • Live singleton gestation ≥37 weeks
- • History of 1 cesarean delivery
- • ≥18 years of age
- • Cephalic presentation
- • Intact membranes
- • English or Spanish speaking (Able to read/understand consent and instructions)
- • Cervical dilation \<3cm and Bishop score \<8
- Exclusion Criteria:
- • \>1 prior Cesarean delivery
- • Known chorioamnionitis
- • Major fetal anomaly
About University Of Pennsylvania
The University of Pennsylvania, a prestigious Ivy League institution located in Philadelphia, is renowned for its commitment to advancing medical research and improving healthcare outcomes. As a clinical trial sponsor, the university leverages its extensive resources, interdisciplinary expertise, and cutting-edge facilities to conduct innovative studies across various therapeutic areas. With a focus on translating scientific discoveries into clinical applications, the University of Pennsylvania fosters collaborations among leading researchers, clinicians, and industry partners, ensuring rigorous trial design and adherence to ethical standards. Through its dedication to excellence in research and education, the university plays a pivotal role in shaping the future of medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Philadelphia, Pennsylvania, United States
Patients applied
Trial Officials
Lisa Levine, MD MSCE
Principal Investigator
University of Pennsylvania
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported